Mylan Asks Fed Circ. To End Doryx ANDA Injunction
Mylan Pharmaceuticals Inc. sought to convince the Federal Circuit on Tuesday to overturn an injunction barring it from manufacturing a generic version of Warner Chilcott LLC's oral antibiotic Doryx pending a...To view the full article, register now.
Already a subscriber? Click here to view full article